Chapter Clinical Summary
Academic synthesis, diagnostic methodology, and surgical recommendationsOsteoporotic vertebral insufficiency fractures (VIF / OVCF) occur when physiological mechanical loads exceed the load-bearing capacity of demineralized, structurally weakened trabecular bone. They represent the most common fragility fracture in the elderly population, carrying substantial morbidity, debilitating axial pain, chronic kyphotic spinal deformity, impaired pulmonary function, decreased physical mobility, and increased mortality. Diagnosis requires detailed clinical history (acute axial back pain following minor exertion or low-energy falls) and multi-detector CT/MRI evaluation. MRI with STIR and T2 fat-suppressed sequences is essential to distinguish acute fractures (bone marrow edema) from chronic, healed compression fractures, evaluate posterior wall cortical integrity, and rule out underlying pathological fractures (multiple myeloma, metastatic disease) or avascular vertebral osteonecrosis (Kümmell disease / intravertebral vacuum cleft). Initial treatment is conservative with multimodal analgesia, brief relative bed rest, and functional orthotic support (TLSO/LSO bracing) combined with systematic anti-osteoporotic medical therapy (bisphosphonates, denosumab, teriparatide). In patients with intractable pain refractory to conservative therapy, vertebral body collapse with mechanical instability, or Kümmell osteonecrosis, minimally invasive percutaneous vertebral augmentation—vertebroplasty (direct PMMA cement injection) or balloon kyphoplasty (balloon cavity creation followed by low-pressure PMMA delivery)—provides rapid, durable pain relief and biomechanical stabilization.
To present the clinical evaluation, classification systems, imaging criteria, and conservative versus percutaneous interventional management of osteoporotic vertebral insufficiency fractures. The reader should be able to differentiate acute from chronic fractures and pathological fractures using MRI; apply the Genant semiquantitative classification and the DGOU Osteoporotic Fracture (OF) classification; execute conservative medical and pharmacological therapy; master the technical steps of percutaneous vertebroplasty and balloon kyphoplasty; and prevent cement leakage and adjacent level fractures.
Osteoporotic bone loss decreases trabecular connectivity and cortical thickness, making vertebral bodies vulnerable to axial microfractures and wedge collapse. Multi-detector CT defines cortical fracture lines, posterior wall retropulsion, and intravertebral vacuum clefts (Kümmell disease). Magnetic resonance imaging (MRI) is the gold standard: acute fractures demonstrate intense bone marrow edema (hypointense on T1, hyperintense on T2/STIR); chronic healed fractures demonstrate normal fatty marrow signaling without edema. Diffuse homogenous marrow infiltration, pedicle involvement, soft tissue epidural mass, and multi-level involvement suggest malignant pathological fracture rather than benign osteoporotic insufficiency.
The Genant semiquantitative visual grading classifies vertebral height loss: Grade 0 (normal, <20% height loss); Grade 1 (mild, 20–25% height reduction in anterior, middle, or posterior height); Grade 2 (moderate, 25–40% height reduction); Grade 3 (severe, >40% height collapse). The German Society for Orthopaedics and Trauma (DGOU) Osteoporotic Fracture (OF) classification evaluates morphology and biomechanical stability: OF 1 (edema without fracture deformity); OF 2 (deformation without or with minor posterior wall involvement); OF 3 (distinct fracture with posterior wall breach involving one endplate); OF 4 (loss of vertebral integrity / complete burst or frame fracture); OF 5 (distraction or rotation injury).
Conservative therapy: standard initial treatment for stable fractures without neurological deficit, combining multimodal analgesia, early protected mobilization with a lightweight semi-rigid TLSO/LSO brace, and anti-osteoporotic pharmacotherapy (teriparatide anabolic therapy promotes fracture healing; bisphosphonates/denosumab reduce secondary fracture risk). Percutaneous Vertebral Augmentation (Vertebroplasty and Balloon Kyphoplasty): indicated for severe intractable pain failing 3–6 weeks of conservative care, progressive kyphotic collapse, or Kümmell osteonecrosis. Kyphoplasty inserts inflatable balloons into the vertebral body to partially restore height and create a contained cavity, allowing low-pressure injection of high-viscosity polymethylmethacrylate (PMMA) cement. Technical complications include PMMA cement leakage into epidural veins (pulmonary cement embolism), neural foramina, or spinal canal, which is minimized by biplane continuous fluoroscopy, high-viscosity cement, and strict volume control.
In clinical practice, managing osteoporotic vertebral fractures begins with non-operative medical care and targeted osteoporosis investigation (DEXA scan, serum calcium, 25-OH vitamin D, protein electrophoresis). When a patient experiences persistent severe focal back pain that prevents upright mobilization despite 3–4 weeks of optimal analgesia and bracing, obtain an updated MRI: confirming active STIR hyperintensity (bone marrow edema) at the fractured level establishes eligibility for percutaneous balloon kyphoplasty or vertebroplasty. Review the pre-procedural CT scan meticulously: if a major posterior wall breach is present, exercise extreme vigilance during cement injection, injecting small volumes (2–4 mL) of high-viscosity doughy PMMA under continuous real-time lateral fluoroscopy, immediately halting injection if posterior wall migration or epidural venous filling is noted. In Kümmell disease (avascular osteonecrosis with fluid/air-filled cleft), balloon kyphoplasty fills the nonunion cavity, providing dramatic immediate pain relief and preventing progressive pseudarthrotic kyphosis.